Incyte (INCY) – FDA
-
Incyte (INCY) and CMS Enter License Agreement for Povorcitinib in China and Southeast Asia
-
Incyte (INCY) Announces U.S. Food and Drug Administration Grants Priority Review for Axatilimab for the Treatment of Chronic Graft-Versus-Host Disease
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to INCY Stock Lookup